¶ ELMO1 Protein — Engulfment and Cell Motility 1
Elmo1 Protein Engulfment And Cell Motility 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ELMO1 (Engulfment and Cell Motility 1) is a cytoplasmic protein that functions as a critical mediator of phagocytosis and cell migration. It works in conjunction with DOCK proteins to activate Rho GTPases, particularly Rac1, to orchestrate actin remodeling during engulfment processes [1].
ELMO1 is a modular protein with multiple functional regions:
- Molecular Weight: ~85 kDa
- Structure: Multiple domains mediating protein-protein interactions
¶ Functional Domains
- N-terminal Domain: Contains a proline-rich region andArmadillo repeats
- PH Domain: Phosphoinositide binding
- C-terminal Region: Mediates interaction with DOCK proteins
ELMO1 is essential for efficient phagocytosis:
- Apoptotic Cell Clearance: Mediates recognition and engulfment of apoptotic cells [2]
- Phagosome Formation: Helps form the phagocytic cup through actin polymerization
- Rac1 Activation: Recruits and activates Rac1 via DOCK proteins
- Actin Remodeling: Orchestrates actin cytoskeleton changes
ELMO1 participates in several cellular processes:
- Cell Migration: Required for cell motility in various cell types
- Neuronal Development: Involved in neuronal migration and process extension
- Immune Cell Function: Critical for macrophage and microglial phagocytosis
In microglia, ELMO1 is particularly important:
- Synaptic Pruning: Mediates developmental synaptic elimination [3]
- Aggregate Clearance: Engulfs protein aggregates and cellular debris
- Immune Surveillance: Supports microglial scanning and response
ELMO1 has been implicated in PD through microglial function:
- Alpha-synuclein Clearance: Microglial phagocytosis of alpha-synuclein requires ELMO1 [4]
- Neuroinflammation: Contributes to microglial activation states
- Genetic Associations: ELMO1 variants may modify PD risk
- Amyloid Clearance: Mediates microglial phagocytosis of amyloid-beta [5]
- Synaptic Pruning: May contribute to synaptic loss in AD
- Neuroinflammation: Dysregulated function promotes harmful inflammation
- Debris Clearance: Clears cellular debris from degenerating neurons
- Neuroinflammation: Modulates microglial responses
- Disease Progression: May influence rate of progression
ELMO1 represents a potential therapeutic target:
- Modulating Phagocytosis: Enhancing beneficial clearance while limiting harmful inflammation
- Microglial Function: Targeting ELMO1 may help balance microglial responses
- Brugnera et al., ELMO function (2002)
- Cox et al., Phagocytosis mechanism (2001)
- Schafer et al., Synaptic pruning (2012)
- Bliederhaeuser et al., Microglia in PD (2016)
- Huang et al., ELMO1 in AD (2019)
The study of Elmo1 Protein Engulfment And Cell Motility 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Wang et al., ELMO1 in phagocytosis and cell migration (Cell, 2005)
- Kang et al., ELMO1 in neuronal development and regeneration (Developmental Neurobiology, 2018)
- Zhang et al., ELMO1 in Parkinson's disease and alpha-synuclein clearance (Autophagy, 2020)
- Fitzgerald et al., ELMO1 in neuroinflammation and microglia activation (Journal of Neuroinflammation, 2019)
- Gao & Chen, ELMO1 in cell death and survival pathways (Cell Death & Disease, 2017)
- Hochreiter-Hufford & Ravichandran, ELMO1 and apoptotic cell clearance (Cold Spring Harbor Perspectives in Biology, 2013)
- Martinez & Ng, ELMO1 in immune signaling and neurodegeneration (Frontiers in Cellular Neuroscience, 2019)
- Brahma & Kumar, ELMO1 in cytoskeletal dynamics (Cellular and Molecular Life Sciences, 2016)